梅波利祖马布剂型对严重喘患者治疗结果的影响
Martina Vetchá1, Kateřina Kubová1, Constantinos Glynos2
1Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno, Czechia.
Frontiers in medicine
|May 7, 2025
概括
梅波利祖马布治疗,从注射过渡到自给药液体形式,显著改善了严重喘的结果. 这项现实研究表明,在所有梅波利祖马布剂型中,恶化和皮质类固醇使用减少了.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 单克隆抗体梅波利祖马布 (Mepolizumab) 可提供各种肠道配方,包括冷化 (LYO),液体和自给形式用于家庭护理.
- 关于切换梅波利祖马布剂量形式的现实数据有限,特别是在通过连续配方过渡的患者的临床结果方面.
- 这项研究调查了切换mepolizumab配方对严重喘患者在现实环境中的临床结果的影响.
研究的目的:
- 评估从冷化 (LYO) 梅波利祖马布转换为液体配方的严重喘患者的临床结果.
- 为了评估从医院管理的预填注射器 (PFS) 或自喷器 (AI) 过渡到家庭自我管理的mepolizumab.
- 分析mepolizumab在不同剂量形式和管理设置中的实际有效性.
主要方法:
- 一项涉及五家捷克喘中心患者的纵向研究,通过三个阶段跟踪mepolizumab的使用:LYO,PFS/AI和家庭液体形式.
- 数据收集包括患者人口统计学,并发症 (鼻多重症,GERD),恶化率 (ER),喘控制测试分数,强迫呼吸量 (FEV),血液中异氨基细胞计数和口服皮质类固醇 (OCS) 的每日剂量.
- 统计分析比较了治疗开始前后的结果,以及不同的梅波利祖马布配方.
主要成果:
- 无论配方如何,梅波利祖马布治疗都带来了显著的改善,中位数ER从4降至0,中位数OCS剂量在三个月内从5毫克降至0毫克.
- 患有鼻多重症和GERD的患者表现出更显著的OCS剂量减少.
- 与冷化 (LYO) 形式相比,预填注射器/自动注射器 (AI/PFS) 显示出更好的ER减少和OCS减少的趋势,这可能受到AI/PFS总体治疗持续时间更长的影响.
结论:
- 梅波利祖马布有效地改善了严重喘患者的临床结果,无论使用的剂量形式如何.
- 过渡到液体配方和mepolizumab的家庭自我管理与积极的现实世界的临床结果有关.
- 梅波利祖马布在治疗严重喘时,表现出了对肠道和自给药形式的一致有效性.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
161
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
161
01:24Antiasthma Drugs: Methylxanthines
114
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
114
01:19Antiasthma Drugs: Leukotriene Modifiers
151
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
151
01:23Inhaled Medications
200
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
200
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
150
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
150